Metastatic Kidney Cancer

14 clinical trials · Condition

Record	Firm	Date
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04385654)	West China Hospital	2020-06-01
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy (NCT04623502)	University of Texas Southwestern Medical Center	2019-09-30
Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer (NCT03846128)	University Hospital, Rouen	2019-06-03
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma (NCT03280667)	Australian and New Zealand Urogenital and Prostate Cancer Trials Group	2017-12-12
Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas (NCT03189186)	University of California, Irvine	2017-07-01
Immunotherapy Study for Metastatic Renal Cell Cancer (NCT02035358)	NewLink Genetics Corporation	2015-05-01
Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer (NCT01355562)	Loma Linda University	2011-03-01
Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer (NCT00942058)	Centre Hospitalier Universitaire de Saint Etienne	2009-06-01
Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer (NCT01336231)	Centre Francois Baclesse	2008-10-01
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer (NCT00328861)	National Cancer Institute (NCI)	2006-05-01

Track Metastatic Kidney Cancer automatically

Every clearance here is in the API, with alerts when new ones post.